Beata Gromadzka

Dr. Beata Gromadzka

orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2014 in Biosensors and Bioelectronics
Verified
Journal Article
Open access
DNDawid Nidzworski
Dawid Nidzworski
PPPaulina Pranszke
Paulina Pranszke
MGMagda Grudniewska-Lawton
Magda Grudniewska-Lawton
EKEwelina Krol
Ewelina Krol
Beata GromadzkaBeata Gromadzka
Beata Gromadzka
Influenza is a contagious disease caught by humans caused by viruses belonging to the family Orthomyxoviridae. Each year, the influenza virus infects millions of people and kills hundreds of thousands of them. Traditional diagnostic methods, such as virus propagation and isolation, antigen capture immunoassays and molecular methods are not sufficient for the detection of the influenza virus. Development of a valid diagnostic assay for quick detection (in less than an hour) of the virus, with high sensitivity, is a challenge for researchers all over the world. Here we present a new, universal immunosensor for detection of the influenza A virus. By using electrochemical impedance spectroscopy (EIS) and direct attachment of antibodies to the gold electrode the assay allows detection of the pathogen with sensitivity similar to molecular methods in relatively short time. Application of universal anti-M1 antibodies allows detection of all serotypes of influenza A virus. The simple design of the sensor facilitates miniaturization of the device and its implementation for routine diagnostics during first contact with the patient, before applying a proper treatment.

8 April 2022 in Biosensors and Bioelectronics
Verified
Journal Article
Closed access
WBWioleta Białobrzeska
Wioleta Białobrzeska
MFMateusz Ficek
Mateusz Ficek
BDBartłomiej Dec
Bartłomiej Dec
Silvio OsellaSilvio Osella
Silvio Osella
Bartosz TrzaskowskiBartosz Trzaskowski
Bartosz Trzaskowski
RBRobert Bogdanowicz
Robert Bogdanowicz

3 February 2020 in Sensors
Verified
Journal Article
Open access
PDF file
MJMarta Janczuk-Richter
Marta Janczuk-Richter
Beata GromadzkaBeata Gromadzka
Beata Gromadzka
LRLukasz Richter
Lukasz Richter
MPMirosława Panasiuk
Mirosława Panasiuk
KZKarolina Zimmer
Karolina Zimmer
Joanna Niedziółka-JönssonJoanna Niedziółka-Jönsson
Joanna Niedziółka-Jönsson
Since the norovirus is the main cause of acute gastroenteritis all over the world, its fast detection is crucial in medical diagnostics. In this work, a rapid, sensitive, and selective optical fiber biosensor for the detection of norovirus virus-like particles (VLPs) is reported. The sensor is based on highly sensitive long-period fiber gratings (LPFGs) coated with antibodies against the main coat protein of the norovirus. Several modification methods were verified to obtain reliable immobilization of protein receptors on the LPFG surface. We were able to detect 1 ng/mL norovirus VLPs in a 40-min assay in a label-free manner. Thanks to the application of an optical fiber as the sensor, there is a possibility to increase the user’s safety by separating the measurement point from the signal processing setup. Moreover, our sensor is small and light, and the proposed assay is straightforward. The designed LPFG-based biosensor could be applied in both fast norovirus detection and in vaccine testing.

13 April 2016 in Microbial Cell Factories
Verified
Journal Article
Open access
PDF file
ACAnna Czarnota
Anna Czarnota
JTJolanta Tyborowska
Jolanta Tyborowska
GPGrażyna Peszyńska-Sularz
Grażyna Peszyńska-Sularz
Beata GromadzkaBeata Gromadzka
Beata Gromadzka
KBKrystyna Bienkowska-Szewczyk
Krystyna Bienkowska-Szewczyk
KGKatarzyna Grzyb
Katarzyna Grzyb
Hepatitis C virus (HCV) infection is a major health problem worldwide, affecting an estimated 2–3 % of human population. An HCV vaccine, however, remains unavailable. High viral diversity poses a challenge in developing a vaccine capable of eliciting a broad neutralizing antibody response against all HCV genotypes. The small surface antigen (sHBsAg) of hepatitis B virus (HBV) has the ability to form highly immunogenic subviral particles which are currently used as an efficient anti-HBV vaccine. It also represents an attractive antigen carrier for the delivery of foreign sequences. In the present study, we propose a bivalent vaccine candidate based on novel chimeric particles in which highly conserved epitope of HCV E2 glycoprotein (residues 412–425) was inserted into the hydrophilic loop of sHBsAg. The expression of chimeric protein was performed in an unconventional, Leishmania tarentolae expression system resulting in an assembly of particles which retained immunogenicity of both HCV epitope and sHBsAg protein. Direct transmission electron microscopy observation and immunogold staining confirmed the formation of spherical particles approximately 22 nm in diameter, and proper foreign epitope exposition. Furthermore, the sera of mice immunized with chimeric particles proved reactive not only to purified yeast-derived sHBsAg proteins but also HCV E2 412–425 synthetic peptide. Most importantly, they were also able to cross-react with E1E2 complexes from different HCV genotypes. For the first time, we confirmed successful assembly of chimeric sHBsAg virus-like particles (VLPs) in the L. tarentolae expression system which has the potential to produce high-yields of properly N-glycosylated mammalian proteins. We also proved that chimeric Leishmania-derived VLPs are highly immunogenic and able to elicit cross-reactive antibody response against HCV. This approach may prove useful in the development of a bivalent prophylactic vaccine against HBV and HCV and opens up a new and low-cost opportunity for the production of chimeric sHBsAg VLPs requiring N-glycosylation process for their proper functionality and immunogenicity.

25 October 2022 in Polymers
Verified
Journal Article
Open access
PDF file
MCMilena Chraniuk
Milena Chraniuk
MPMirosława Panasiuk
Mirosława Panasiuk
Lilit HovhannisyanLilit Hovhannisyan
Lilit Hovhannisyan
SNSabina Nidzworska
Sabina Nidzworska
DNDawid Nidzworski
Dawid Nidzworski
Beata GromadzkaBeata Gromadzka
Beata Gromadzka
Background: Cytotoxicity testing is a primary method to establish the safety of biomaterials, e.g., biocomposites. Biomaterials involve a wide range of medical materials, which are usually solid materials and are used in bone regeneration, cardiology, or dermatology. Current advancements in science and technology provide several standard cytotoxicity testing methods that are sufficiently sensitive to detect various levels of cellular toxicity, i.e., from low to high. The aim was to compare the direct and indirect methodology described in the ISO guidelines UNE-EN ISO 10993-5:2009 Part 5. Methods: Cell proliferation was measured using WST-1 assay, and cytotoxicity was measured using LDH test kit. Results: The results indicate that the molecular surface of biomaterials have impact on the cytotoxicity and proliferation profile. Based on these results, we confirm that the indirect method does not provide a clear picture of the cell condition after the exposure to the surface, and moreover, cannot provide complete results about the effects of the material. Conclusions: Comparison of both methods shows that it is pivotal to investigate biomaterials at the very early stages using both indirect and direct methods to access the influence of the released toxins and surface of the material on the cell condition.

29 May 2023 in Polymers
Verified
Journal Article
Open access
PDF file
MBMonika Biernat
Monika Biernat
ASAnna Wanda Sylla
Anna Wanda Sylla
MCMilena Chraniuk
Milena Chraniuk
MPMirosława Panasiuk
Mirosława Panasiuk
PTPaulina Tymowicz-Grzyb
Paulina Tymowicz-Grzyb
ZJZbigniew Jaegermann
Zbigniew Jaegermann
Chitosan is one of the most commonly employed natural polymers for biomedical applications. However, in order to obtain stable chitosan biomaterials with appropriate strength properties, it is necessary to subject it to crosslinking or stabilization. Composites based on chitosan and bioglass were prepared using the lyophilization method. In the experimental design, six different methods were used to obtain stable, porous chitosan/bioglass biocomposite materials. This study compared the crosslinking/stabilization of chitosan/bioglass composites with ethanol, thermal dehydration, sodium tripolyphosphate, vanillin, genipin, and sodium β-glycerophosphate. The physicochemical, mechanical, and biological properties of the obtained materials were compared. The results showed that all the selected crosslinking methods allow the production of stable, non-cytotoxic porous composites of chitosan/bioglass. The composite with genipin stood out with the best of the compared properties, taking into account biological and mechanical characteristics. The composite stabilized with ethanol is distinct in terms of its thermal properties and swelling stability, and it also promotes cell proliferation. Regarding the specific surface area, the highest value exposes the composite stabilized by the thermal dehydration method.